Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhur Nayan

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
JAMA Network Open|May 19, 2023
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder CancerMarc S Weinberg, Affan Zafar, Colin Magdamo, et al.
The Journal of Urology|February 18, 2014
Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohortChristopher M Russell, Patrick N Espiritu, Wassim Kassouf, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
Journal of the American Medical Informatics Association : JAMIA|January 8, 2025
AI as an intervention: improving clinical outcomes relies on a causal approach to AI development and validationShalmali Joshi, Iñigo Urteaga, Wouter A C van Amsterdam, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
Urologic Oncology|March 20, 2025
Impact of tobacco use on postoperative complications following partial nephrectomyJosé Ignacio Nolazco, Kevin R Melnick, Jeffrey Che-Wei Chang, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
JAMA Network Open|May 19, 2023
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder CancerMarc S Weinberg, Affan Zafar, Colin Magdamo, et al.
The Journal of Urology|February 18, 2014
Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohortChristopher M Russell, Patrick N Espiritu, Wassim Kassouf, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
Journal of the American Medical Informatics Association : JAMIA|January 8, 2025
AI as an intervention: improving clinical outcomes relies on a causal approach to AI development and validationShalmali Joshi, Iñigo Urteaga, Wouter A C van Amsterdam, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
Urologic Oncology|March 20, 2025
Impact of tobacco use on postoperative complications following partial nephrectomyJosé Ignacio Nolazco, Kevin R Melnick, Jeffrey Che-Wei Chang, et al.
Pageof 6